文献速递头颈部肿瘤放疗放疗物理与技术

头颈部鳞癌肿瘤体素剂量响应矩阵与生物标志物表达的相关性

Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma.
PubMed 文献 · Radiother Oncol · 2021-10-04

本研究纳入28例接受自适应放疗的头颈鳞癌患者,对治疗前活检组织进行CD44、EGFR、GLUT1、ALDH1、Ki-67和p53免疫组化染色,并与治疗前SUVmax及剂量响应矩阵(DRM)参数进行相关性分析。结果发现CD44表达与DRM大于0.8的肿瘤体积呈显著正相关(p=0.0088),GLUT1表达与最大SUV0及SUV0大于20的肿瘤体积相关,而SUVmax与DRM参数互不相关,提示二者为独立影像参数。

要点

  • CD44表达与DRM大于0.8的肿瘤体积显著正相关(p=0.0088)。
  • SUVmax各参数与DRM各参数之间均无相关性,属独立影像参数。
  • GLUT1表达与最大SUV0及SUV0大于20的肿瘤体积相关。

核心结论

  • 治疗前SUVmax与DRM是独立影像参数,二者结合可预测局部复发。
  • CD44表达与DRM大于0.8的肿瘤体积显著正相关,支持癌症干细胞(CSC)随机分布于特定微环境并驱动复发的概念。
  • 对上述小区域实施剂量绘画可能改善肿瘤控制。

研究设计与样本

  • 研究纳入28例进入机构自适应放疗试验的头颈鳞癌患者,治疗期间每周采集FDG-PET图像。
  • 对治疗前活检组织进行CD44、EGFR、GLUT1、ALDH1、Ki-67和p53免疫组化染色并用图像分析定量。
  • 将标志物表达水平与既往推导的影像参数(治疗前SUVmax和DRM)进行相关性分析。

主要发现

  • SUVmax各参数与DRM各参数之间互不相关。
  • CD44表达与DRM大于0.8的肿瘤体积呈正向且高度显著相关(p=0.0088)。
  • 任何DRM参数与GLUT1、p53、Ki-67、EGFR或ALDH1均无相关性。
  • GLUT1表达与最大SUV0及SUV0大于20的肿瘤体积相关。

关键数值与推荐

  • CD44表达与DRM大于0.8的肿瘤体积相关性p=0.0088。
  • GLUT1表达与最大SUV0及SUV0大于20的肿瘤体积相关。
  • DRM大于0.8和SUV0大于20为文中用于相关性分析的影像阈值。

临床怎么用

  • 治疗前可同时评估SUVmax与DRM,二者独立提供局部复发预测信息。
  • CD44高表达且DRM大于0.8体积较大的区域可能为复发相关细胞巢,可考虑剂量绘画。
  • GLUT1表达与高SUV0区域相关,提示代谢影像可反映部分缺氧相关生物学特征。

局限性

  • 样本量仅28例,来自单机构自适应放疗试验。
  • 仅为相关性分析,未验证剂量绘画的临床获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We have developed a novel imaging analysis procedure that is highly predictive of local failure after chemoradiation in head and neck cancer. In this study we investigated whether any pretreatment biomarkers correlated with key imaging parameters. METHODS: Pretreatment biopsy material was available for 28 patients entered into an institutional trial of adaptive radiotherapy in which FDG-PET images were collected weekly during treatment. The biopsies were immunohistochemically stained for CD44, EGFR, GLUT1, ALDH1, Ki-67 and p53 and quantified using image analysis. Expression levels were correlated with previously derived imaging parameters, the pretreatment SUVmax and the dose response matrix (DRM). RESULTS: The different parameters of the SUVmax and DRM did not correlate with each other. We observed a positive and highly significant (p = 0.0088) correlation between CD44 expression and volume of tumor with a DRM greater than 0.8. We found no correlation between any DRM parameter and GLUT1, p53, Ki-67 and EGFR or ALDH1. GLUT1 expression did correlate with the maximum SUV0 and the volume of tumor with an SUV0 greater than 20. CONCLUSIONS: The pretreatment SUVmax and DRM are independent imaging parameters that combine to predict local recurrence. The significant correlation between CD44 expression, a known cancer stem cell (CSC) marker, and volume of tumor with a DRM greater than 0.8 is consistent with concept that specific foci of cells are responsible for tumor recurrence and that CSCs may be randomly distributed in tumors in specific niches. Dose painting these small areas may lead to improved tumor control.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Yan A, Hanna A, Wilson TG, et al. Correlation between tumor voxel dose response matrix and tumor biomarker profile in patients with head and neck squamous cell carcinoma. Radiother Oncol. 2021. PMID: 34619238. doi:10.1016/j.radonc.2021.09.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。